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Abstract
Halogen bonding in ligand-protein complexes is currently widely exploited, e.g. in drug design or supramolecular chemistry.
But little attention has been directed to other effects that may result from replacement of a hydrogen by a strongly
electronegative halogen. Analysis of almost 30000 hydrogen bonds between protein and ligand demonstrates that the
length of a hydrogen bond depends on the type of donor-acceptor pair. Interestingly, lengths of hydrogen bonds between
a protein and a halogenated ligand are visibly shorter than those estimated for the same family of proteins in complexes
with non-halogenated ligands. Taking into account the effect of halogenation on hydrogen bonding is thus important when
evaluating structural and/or energetic parameters of ligand-protein complexes. All these observations are consistent with
the concept that halogenation increases the acidity of the proximal amino/imino/hydroxyl groups and thus makes them
better, i.e. stronger, H-bond donors.
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Introduction
Specific non-covalent interactions of low-mass ligands with
proteins drive properties of the enzymatic machinery in a living
cell. According to (induced) key-lock theory (see [1] for review) a
low-mass ligand should fit to a dedicated binding site that is
accessible on the protein surface. This steric compatibility, known
as van der Waals interactions, dominates ligand-protein selectivity,
simply excluding the majority of putative ligands and favoring
these that fit to the protein binding site. Other types of interactions
modulate the stability of ligand-protein complexes. The strongest
ones are electrostatic interactions between charged groups (known
as salt-bridges, formally zero momentum in multipole expansion of
electrostatic interactions), which energy frequently exceeds
10 kcal/mol.
Hydrogen bonding is the next type of interactions proven to
contribute significantly to stabilization of protein structure and to
the organization of intermolecular complexes (ca. 3 to 5 kcal/mol).
The energy of a single hydrogen bond (H-bond) in ligand-protein
complexes depends both on the type of hydrogen bond donor (D)
and acceptor (A) and on the overall geometry of the D-HNNNA
system. The shortest H-bonds are observed for oxygen acting as a
donor, OHNNNO (2.70A˚) and OHNNNN (2.88A˚), respectively. When
nitrogen is an H-bond donor, its distance to an acceptor is longer:
NHNNNO (3.04A˚) and NHNNNN (3.10A˚), respectively [2]. Subse-
quently, numerous non-canonical weak H-bonds have been
identified by statistical analyses of protein structures, and
previously identified in crystals of low-mass compounds. This
includes, amongst others, a p electron system acting as an H-bond
acceptor [3–5], and an aliphatic carbon acting as an H-bond
donor [4,6,7].
During the last decade, halogen bonding (X-bond, see [8] for
review) has been recognized to play a similar role as H-bonding in
protein-ligand complexes. Halogen bonds have been identified in
many crystal structures of low-mass compounds and their
supramolecular ensembles [8–17], as well as in complexes of
biomolecules with halogenated ligands [18–20]. Bearing in mind
that numerous natural drugs, and an increasing number of
synthetic drug candidates, are halogenated [21–23]; understand-
ing the nature and thermodynamics of halogen bonding should
contribute to rational drug design. Currently, halogenated
compounds are widely used in screening libraries, and comprise
almost 20% of low-mass protein ligands listed in the Protein Data
Bank (PDB). The role of halogenated ligands in biological systems
has been widely reviewed, amongst others, by Auffinger et al. [18],
Parisini et al. [24], Rendine et al., Voth & Ho [25], Voth et al. [26],
Wilcken et al. [27] and Poznan´ski & Shugar [28].
However, there is some controversy about the energy of a
halogen bond. In aqueous medium estimates of intra- or
intermolecular halogen bonds vary from 0.2 [29] up to 5–
8 kcal/mol [25], suggesting that, in biological systems, halogen-
and hydrogen bonds may be of similar strength. However, the
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apparently largest values for an X-bond were obtained ab initio for
CF3-XNNNNH3 systems: 2.3, 4.7 and 6.4 kcal/mol for X=Cl, Br
and I, respectively [30]. These values agree with energies
estimated by IR spectroscopy, for CF3-XNNNN(CH3)3 in liquid
noble gases, which are the best models for a non-polar solvent that
does not interfere with solute-solute interactions: 2.1, 4.4 and
6.8 kcal/mol for X-bonds involving Cl, Br and I, respectively [31–
33]. These halogen bonds can compete with hydrogen bonding, as
well documented for numerous low-mass complexes in silico
[34,35], in solution [36,37], and in the solid state [17,38,39].
Due to this revived interest in halogen bonding, the observed
effect of a halogen atom on structural stability [25,40], or ligand
binding [41,42], has been attributed to a direct effect of halogen
bonding only. However, the strong electronegative and hydro-
phobic character of halogen atoms may also contribute to intra-
and intermolecular interactions. For example we have recently
shown that inhibitory activities (IC50) against protein kinase CK2a
observed for a series of benzotriazoles brominated on the benzene
ring can be explained by a balance of hydrophobic and
electrostatic interactions [43].
Halogenation modulates electron density on proximal donors
and acceptors of hydrogen bonds [44], as well as changes in
protonation equilibria of proximal dissociable groups [45,46].
Well-known examples include the decrease in pKa of fluorinated
alcohols [47]: ethanol vs. 2,29,20-trifluoroethanol (pKa decrease by
3.45) and phenol vs. pentafluorophenol (pKa decrease by 4.4).
Likewise, halogenation of uracil was shown to reduce the
hydrogen-bond-accepting, and to increase the hydrogen-bond-
donating, capabilities of halogenated DNA bases [48–50]. Other
illustrative examples of the direct effect of a halogen atom on
strengthening of proximal hydrogen bonds are brominated natural
[51,52] and synthetic [53–55] DNA, which were found to be
much more stable than the corresponding non-brominated
analogues.
A further example of the foregoing is the report of Xu et al. [42]
on a series of closely related halogenated inhibitors of phospho-
diesterase 5 (PDE5). There are five PDB structures of PDE5 with
bound inhibitors that differ only by substitution of a hydrogen
atom by F, Cl, Br or I, respectively (see PDB entries 3TSE, 3SHY,
3SHZ, 3SIE, 3TSF). Location of these closely related ligands in
the binding pocket was judged to be stabilized, besides two
hydrogen bonds and numerous vdW interactions, by intermolec-
ular interaction between the halogen atom (X) and the hydroxyl
oxygen of Tyr612. However, there are also two intermolecular
hydrogen bonds between the side-chain of Gln817, and ligands
Od and Ns, respectively, both proximal to the halogen atom (3
chemical bonds distance). Changes in the lengths of these, upon
variation of the halogen substituent, reflects eventual strengthening
of these H-bonds, not taken into account by the authors [42].
To our knowledge, no high-throughput analyses addressing the
effect of a halogen atom on proximal hydrogen bond(s) have yet
been reported for ligand-protein systems [13,19,24,25,56–61]. We
herein analyze the effect of the halogen atom of a halogenated
ligand on the lengths of hydrogen bonds (both proximal and
distal), identified in two families of proteins: protein kinases (EC
2.7) and acyltransferases (EC 2.3).
Results and Discussion
1 PDB Screening
To avoid the eventual effect of protein-specific ligand binding
modes, two protein families were analyzed. Protein kinases (EC
2.7) and acyltransferases (EC 2.3) are the proteins for which the
largest number of structures with halogenated ligands was
identified in the PDB. All complexes of ligands with proteins of
these two families were analyzed. A total of 3852 PDB entries was
found, 3187 with non-halogenated ligands, LH, 505 with
fluorinated ones, LF, and 408 containing halogenated (not
fluorinated) ligands, LX, contributing together to 1228 records
of acyltransferases and 2624 records of protein kinases. After
exclusion of protein sulfur as either hydrogen bond acceptor or
donor, a total number of 24470 hydrogen bonds was identified,
1930 with fluorinated, 1390 with halogenated ligands, and 21150
with non-halogenated ligands, respectively. In addition, 41
intermolecular H-bonds to protein sulfur (Met or Cys) were
excluded from further analyses (see Table 1 for the short statistics).
2 Distribution of Hydrogen Bond Lengths as a Function
of H-bond Topology
Hydrogen bonds were grouped according to eight possible
topologies of hydrogen bond donor-acceptor pairs, i.e. N-
HligNNNOprot (NHNNNO), NligNNNH-Oprot (NNNNHO), O-HligNNNOprot
(OHNNNO), OligNNNH-Oprot (ONNNHO), N-HligNNNNprot (NHNNNN),
NligNNNH-Nprot (NNNNHN), O-HligNNNNprot (OHNNNN), and OligNNNH-
Nprot (ONNNHN). The distributions obtained for non-halogenated
ligands are presented in Figure 1. For ligands acting as H-bond
donors, two left shifted distributions identify the topologies of the
shortest H-bonds types (i.e. OHNNNN and OHNNNO), medians of
which are the lowest (Figure 1A). The intermediate distribution
(NHNNNO) is also characterized by a higher median. The last one
(NHNNNN) is much more shifted to the right, and its median is the
highest. The order of distributions strictly correlates with the
average strength of H-bonds: the shorter is donor-to-acceptor
distance, the stronger is the H-bond. This agrees with a common
order of an average enthalpy of formation of various types of
hydrogen bonds in biomolecules: OHNNNN, 6.9 kcal/mol; OHNNNO,
5.0 kcal/mol; NHNNNN, 3.1 kcal/mol, and NHNNNO, 1.9 kcal/mol,
respectively [62].
Inspection of cumulative distributions for non-halogenated
ligands acting as H-bond acceptors (see Figure 1B) clearly
demonstrated that hydrogen bonds involving two oxygen atoms
are statistically the shortest, as evidenced by the left-shift of the
cumulative distribution function towards shorter distances (and
also smaller medians). H-bonds between two nitrogen atoms are
the longest, and the two remaining types of hydrogen bonds of
mixed topology, NNNNHO and ONNNHN are intermediate in their
lengths.
Formal statistical analysis clearly demonstrated that most
topologies of an H-bond differ significantly according to the H-
bond donor-to-acceptor distance distribution. Interestingly, these
differences are observed even between pairs in which the proton is
swapped between the ligand and the protein. Hence, the
distribution of OHNNNO (OHligNNNOprot) differs from that of an
ONNNHO (OligNNNHOprot), p,10
22. Similarly OHNNNN differs from
ONNNHN (p,?10210) and NHNNNO differs from NNNNHO (p= 0.05).
This significant asymmetry may be a consequence of overrepre-
sentation of several types of H-bond donors and acceptors in
proteins. Namely, oxygen acceptors are dominated by backbone
carbonyls, oxygen donors are Ser, Thr and Tyr hydroxyl groups,
nitrogen donors are mainly backbone amides, and nitrogen donors
are solely the imidazole of His, which are rare in proteins. In
consequence, the protein nitrogen H-bond acceptors are strongly
underrepresented (see column ‘n’ in Table 2).
The foregoing is valid for all types of ligands acting as either
acceptor or donor of an H-bond (see Figure S1 and Table S1). The
statistical significance of the observed differences in donor-
acceptor distance distributions was evaluated, separately for the
three types of ligands, with the aid of the non-parametric Kruskal-
Halogen Atom Affects Hydrogen Bonding
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Wallis test (p,1029). Since these differences were found globally
significant, the post-hoc approach was used to identify those pairs
that significantly differ. Estimated p-values, together with the
number of identified H-bonds, and mean rank of donor-acceptor
distances, are presented in Table 2 and Table S1.
The majority of the analyzed pairs of distributions for non-
halogenated ligands (LH) differ significantly (23 out of 28,
assuming a significance level of 0.05). In the case of fluorinated
(LF) and other halogenated ligands (LX), the small number of
identified hydrogen bonds of the type NNNNHO (NligNNNH-Oprot with
n= 4 or 2 H-bonds found for LH and LX ligands, respectively)
and NHNNNN (NHligNNNNprot with n= 1 and 0, respectively),
precluded analysis of these two types of hydrogen bonds. For the
remaining groups, distributions for 11 out of 14 possible pairs
differ significantly both for fluorinated (LF) and otherwise
halogenated (LX) ligands (Table S1). In this context, the hydrogen
bond lengths to halogenated or non-halogenated ligands must be
compared separately for eight groups representing all possible
topologies of hydrogen bonding in ligand-protein complexes.
Otherwise, the differences in representation of various types of
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Figure 1. Cumulative distributions of donor-acceptor distances
determined for various types of intermolecular hydrogen bond
donor-acceptor pairs identified in complexes of proteins with
non-halogenated ligands, in which the ligand is either a
hydrogen bond donor (A) or acceptor (B).
doi:10.1371/journal.pone.0099984.g001
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hydrogen bonds would contribute in an uncontrolled manner to
the observed distance distributions.
The most common types of ligand-protein intermolecular
hydrogen bonds in the PDB, NHNNNO and ONNNHN, display almost
identical distributions for non-halogenated ligands (LH, see
Figure 2A), but become visibly different for fluorinated (LF) or
otherwise halogenated (LX) ligands (see Figure 2B, C). In both
latter cases the distributions of the NHNNNO hydrogen bond lengths
are shifted left relative to those of the ONNNHN. However, for
fluorinated ligands the medians are, by chance, almost equal. The
observed differences are statistically significant only for haloge-
nated ligands (p = 0.03), but they are also probable for fluorinated
ligands (p = 0.09) (see Table 2). It should be stressed that the
observed differences in medians for fluorinated (LF) and haloge-
nated (LX) ligands (0.01 and 0.03 A˚ respectively, see Table 3)
exceed the precision of PDB records. Overall, this clearly shows
that ligand substitution with electronegative atoms (F, Cl, Br, I)
results in variation of the lengths of intermolecular hydrogen
bonds. Moreover, this effect strongly depends on the type of
hydrogen bond (Table S1).
3 Hydrogen Bonding to Halogenated or Fluorinated vs.
Non-halogenated Ligands
The effect of a halogen atom on the distribution of hydrogen
bond lengths was analyzed separately for the four most abundant
types of hydrogen bonds: OHNNNO, NHNNNO, NNNNHN and ONNNHN
(i.e. a protein oxygen being a hydrogen bond acceptor and a
protein nitrogen being a hydrogen bond donor, see Table 3 for
numbers). Cumulative distributions of hydrogen bond lengths
estimated for fluorinated (LF) and otherwise halogenated (LX)
ligands are, for some of the H-bond topologies, shifted towards
shorter distances in comparison to non-halogenated ligands (LH).
It is shown in Figure 3, and also confirmed by lower mean ranks
collected in Table 3. Substitution with halogen atom mostly affects
the lengths of OHNNNO hydrogen bonds (Figure 3C). Smaller, but
still visible, changes are observed for NHNNNO (Figure 3A) and
NNNNHN (Figure 3B), while almost no variations are observed for
ONNNHN hydrogen bonds (Figure 3D). This is fully confirmed by
the Mann-Whitney U test (see Table 3, and Table S2 for all H-
bond topologies). Amongst them, hydrogen bonds to fluorinated
ligands (LF) are significantly shorter for five out of seven tested
pairs of distributions, while halogenated ligands (LX) differ
significantly from non-halogenated ones (LH) only for the NHNNNO
type. It should be stressed that the medians for H-bond length with
halogenated ligands (either LF or LX) are generally lower than
those for non-halogenated ones (LH). This can also be easily
checked via mean ranks (LX,LH and LF,LH).
In general the effect of fluorine vs. other halogens atoms follows
the electronegativity scale. Fluorine changes properties of nitrogen
both as acceptor and donor of hydrogen, and oxygen as donor of a
hydrogen bond, whereas chlorine, bromine and iodine affect only
hydrogen bond donors (both oxygen and nitrogen). The latter
effect is clearly detectable for medians (decrease by 0.06 and 0.03
A˚ for OHNNNO and NHNNNO, respectively) and is statistically
significant (p = 0.02 and p,1025, see Table 3 for details). No
variations are observed for halogenated ligands (LX) acting as H-
bond acceptor. It is worth noting that the observed differences
agree with ab initio simulations of base pairing of halogenated
uracil with adenine [48].
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4 Validation of the Differences Observed for Distributions
of H-bond Donor-acceptor Distance
Proteins form H-bonds via various types of donors and
acceptors. In view of the adopted approach, all types of hydrogen
bonds should be analyzed separately, but the number of actually
identified interactions with halogenated ligands makes results of
such detailed analysis statistically insignificant. However, the large
subset of H-bonds between ligands and protein backbone (i.e.
carbonyl oxygen and amide nitrogen) enables analysis of much
more homogenous subsets of protein-ligand interactions. The
results generally agree with those obtained for all protein H-bond
acceptors and donors (see Figure S2), confirming again the
statistical significance of the effect of a halogen atom on lengths of
intermolecular hydrogen bonds between a halogenated ligand and
a protein.
A key point of the presented analysis is the significance of the
results presented in the context of the quality of PDB structures. In
fact, there are only a very limited number of X-ray structures of
closely related halogenated ligands bound to the same protein that
can be compared directly (e.g. PDE5 mentioned in the Introduc-
tion). Moreover, the resolution of X-ray structures precludes any
direct interpretation of distances that differ by an order of 0.01 A˚.
All donor-acceptor distances must be regarded biased, but
differences between observed distributions, as presented in
Figures 1–3, may be considered as significant, since there is no
factor explaining any systematic differences in biases for haloge-
nated and non-halogenated ligands. However, to assess an
eventual effect of quality of structures on the significance of
observed differences in distance distributions, the analyses were
repeated for two subsets of high-resolution X-ray structures,
resolutions of which were better than 2.0 and 1.5 A˚, respectively,
and the general tendency to strengthening of H-bonds between
protein and halogenated ligands (both LF and LX) acting as
hydrogen bond donor was preserved (see Table S3).
Materials and Methods
Structural Data
The Protein Data Bank (PDB, [63]) was searched to identify all
entries of protein kinases (EC 2.7) and acyltransferases (EC 2.3).
Those containing ligands with at least one oxygen/nitrogen bound
to a carbon atom were subjected to further analysis.
Structural Analysis
All analyses were performed with the aid of the Yasara Model
package [64]. For each class of protein, all intermolecular ligand-
protein hydrogen bonds were identified, using 3.5 A˚ as a threshold
for the distance between putative hydrogen bond donor and
acceptor. The distributions of donor-acceptor distances were
determined separately for three classes of ligands: non-halogenated
(LH), fluorinated (LF) and others that are halogenated, but not
fluorinated (LX). These data were then assigned to one of eight
groups, according to the topology of the hydrogen bond. The
latter was defined according to the ligand atom (oxygen or
nitrogen) being either donor or acceptor of a hydrogen bond with
protein nitrogen or oxygen. Since fluorinated ligands (LF) are the
internal reference for the effect of other halogen atoms that may
contribute in halogen bonding (LX), all heterogenic ligands, which
were simultaneously fluorinated and modified with chlorine/
bromine/iodine, were excluded from the analysis.
The most abundant types of hydrogen bonds (i.e. NHligNNNOprot,
OHligNNNOprot, OligNNNHNprot, and NligNNNHNprot) were additionally
analyzed according to homogenous substitutions with only
Fluorine; Chlorine, Bromine or Iodine. All heterogeneously
Figure 2. Cumulative distributions of NHNNNO (blue) and ONNNHN
(red) intermolecular hydrogen bonds identified in protein
complexes with non-halogenated (A, LH), fluorinated (B, LF)
and otherwise halogenated ligands (C, LX). See Table 2 for details.
doi:10.1371/journal.pone.0099984.g002
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substituted ligands (e.g. bromo-fluoro or chloro-iodo) were
excluded from this analysis.
Multiple protein molecules in the crystal cell, as well as objects
displaying partially occupied forms (i.e. side-chain rotamers or
ligand locations) were analyzed separately. Hydrogen bonds with
water molecules were not analyzed.
Statistical Analysis
To circumvent the eventual requirement of categorization, all
distributions are presented in a cumulative manner as a CDF
(cumulative distribution function), which is the integral of a
distribution function. This form of presentation helps in visual
comparison of various distributions, overcoming the problem of
balancing the resolution (i.e. the number of beans in a histogram)
and statistical noise (i.e. numbers of counts in beans). In all figures
the curve most shifted to the left identifies the dataset character-
ized by the shortest donor-acceptor distances.
Since, according to the Anderson-Darling test [65], most
distributions of hydrogen bond donor-acceptor distances were
found not Gaussian (data not shown), the statistical significance of
observed differences was estimated according to nonparametric
tests. For comparison of two distributions the Mann-Whitney U
test [66] was used. The Kruskal-Wallis test [67], which is a
generalization of the U-test, was applied for 3 or more groups.
The Mann-Whitney U-test is a first choice alternative to
Student’s t-test, when applied to two data-sets that are not
necessarily normally distributed. Formally, it detects differences in
shape of tested distributions: each group is characterized by its
mean rank, i.e. the average position of its components in the list
created by sorting both datasets. For each pair of distributions, the
smaller value of the mean rank (Ri) identifies the group that is
characterized by a shorter distance (see Tables 2, 3). The value of
Ui is the corresponding test statistics, (Ui = ni*[Ri2(ni+1)/2]; ni is
the size of dataset i), and ZU is the associated value of the standard
Gaussian distribution. Positive ZU value (equivalently higher mean
rank for LH) indicates that distances for halogenated ligands are
shorter, and the corresponding p-value estimates the statistical
significance of observed differences. The medians were also
Figure 3. Effect of a halogen atom on cumulative distributions determined for the four most abundant types of hydrogen bond
donor-acceptor pairs: NHNNNO (A), OHNNNO (B), NNNNHN (C), and ONNNHN (D), respectively. The distributions estimated for non-halogenated (LH),
fluorinated (LF) and other halogenated ligands (LX) are presented in black, blue and green, respectively. See Table 3 for details.
doi:10.1371/journal.pone.0099984.g003
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compared for selected pairs of distributions according to the
appropriate median test [68].
All analyses were performed using the Statistica 10 [69]. Null
hypotheses that given distributions do not differ one from the other
were tested at a significance level, a=0.05, and those with p-
values below 0.05 were rejected, and distributions regarded as
different.
Conclusions
Hydrogen bond length distributions in protein-ligand com-
plexes are significantly different for non-halogenated ligands
(LH) compared to halogenated ones (LF, LX). The H-bond
donor-acceptor distances are significantly shorter for a haloge-
nated ligand acting as a hydrogen bond donor (at significance
level 0.05). However H-bond lengths seem irrelevant for
halogenations, when the ligand oxygen is a hydrogen bond
acceptor. All these observations are consistent with the idea that
halogenation increases the acidity of proximal amino/imino/
hydroxyl groups and thus makes them better, i.e. stronger, H-
bond donors.
Supporting Information
Figure S1 Cumulative distributions of donor-acceptor distanc-
es determined for various types of intermolecular hydrogen
bond donor-acceptor pairs identified In complexes of proteins
with non-halogenated ligands, in which the ligand is either a
hydrogen bond donor (A, C, E) or acceptor (B, D, F);
determined for non-halogenated, LH, (A, B), fluorinated, LF,
(C, D), and otherwise halogenated (i.e. not fluorinated), LX,
ligands (E, F).
(TIF)
Figure S2 Effect of a halogen atom on cumulative distributions
determined for the donor-acceptor pairs determined for hydrogen
bonds between ligand and protein backbone (carbonyl oxygen:
A, C or amide nitrogen’’ B, D). The distributions estimated for
non-halogenated, fluorinated and otherwise halogenated ligands
are presented in black, blue and red, respectively.
(TIF)
Table S1 Results of the Kruskal-Wallis (K-W) test in the analysis
of the topology-dependent length of a hydrogen bond: for each
pair of hydrogen bond acceptor/donor pair the p-value for the
null hypothesis that both distributions are identical was estimated
according to the two-tailed multiple comparison. The values
marked in bold denote the pairs of distributions that differ one
from the other, with a=0.05. Additionally, the identified number
of each type of hydrogen bond, n, and mean rank test are
presented.
(DOC)
Table S2 Comparison of distributions of hydrogen bond lengths,
calculated separately for halogenated but not fluorinated (LX),
fluorinated (LF), and non-halogenated ligands (LH), for eight
possible topologies of protein-ligand hydrogen bonds. Those for
which hydrogen bonds to LX/LF ligands are, according to the
Mann-Whitney U test, significantly shorter (assuming a=0.05) are
highlighted. Note that for each pair of H-bond distributions, a
smaller mean rank indicates statistically shorter donor-acceptor
distances, or, equivalently, positive values of ZU statistics indicate
these types of H-bonds, which are longer to nonhalogenated
ligands. The corresponding medians, and their differences with
statistical significances (p), are also presented.
(DOC)
Table S3 Comparison of distributions of hydrogen bond lengths,
calculated separately for ligands fluorinated (LF), otherwise
halogenated (LX), and non-halogenated (LH), for hydrogen bonds
between ligand and protein that were identified in high-resolution
X-ray structures.
(DOC)
Author Contributions
Conceived and designed the experiments: JP DS. Analyzed the data: JP
AP. Wrote the paper: JP AP DS.
References
1. Koshland DE (1994) The key-lock theory and the induced fit theory.
Angewandte Chemie-International Edition 33: 2375–2378.
2. Stryer L (1995) Biochemistry (4th edition): W. H. Freeman & Company.
3. Atwood JL, Hamada F, Robinson KD, Orr GW, Vincent RL (1991) X-ray
diffraction evidence for aromatic p hydrogen-bonding to water. Nature 349:
683–684.
4. Aakeroy CB, Seddon KR (1993) The hydrogen-bond and crystal engineering.
Chemical Society Reviews 22: 397–407.
5. Steiner T, Koellner G (2001) Hydrogen bonds with p-acceptors in proteins:
Frequencies and role in stabilizing local 3D structures. Journal of Molecular
Biology 305: 535–557.
6. Taylor R, Kennard O (1982) Crystallographic evidence for the existence of C-
HNNNO, C-HNNNN, and C-HNNNC hydrogen-bonds. Journal of the American
Chemical Society 104: 5063–5070.
7. Desiraju GR (1991) The C-HNNNO hydrogen-bond in crystals - what it is.
Accounts of Chemical Research 24: 290–296.
8. Metrangolo P, Meyer F, Pilati T, Resnati G, Terraneo G (2008) Halogen
bonding in supramolecular chemistry. Angewandte Chemie-International
Edition 47: 6114–6127.
9. Hassel O, Hvoslef J (1954) The Structure of Bromine 1,4-Dioxanate. Acta
Chemica Scandinavica 8: 873–873.
10. Bent HA (1968) Structural chemistry of donor-acceptor interactions. Chemical
Rewievs 68: 587–648.
11. Desiraju GR (1995) Supramolecular synthons in crystal engineering - a new
organic-synthesis. Angewandte Chemie-International Edition in English 34:
2311–2327.
12. Metrangolo P, Resnati G (2001) Halogen bonding: A paradigm in supramo-
lecular chemistry. Chemistry-a European Journal 7: 2511–2519.
13. Metrangolo P, Neukirch H, Pilati T, Resnati G (2005) Halogen bonding based
recognition processes: A world parallel to hydrogen bonding. Accounts of
Chemical Research 38: 386–395.
14. Rissanen K (2008) Halogen bonded supramolecular complexes and networks.
CrystEngComm 10: 1107–1113.
15. Aakeroy CB, Champness NR, Janiak C (2010) Recent advances in crystal
engineering. CrystEngComm 12: 22–43.
16. Mooibroek TJ, Gamez P (2013) Halogen NNN phenyl supramolecular interactions
in the solid state: hydrogen versus halogen bonding and directionality.
CrystEngComm 15: 1802–1805.
17. Mooibroek TJ, Gamez P (2013) Halogen bonding versus hydrogen bonding:
what does the Cambridge Database reveal? Crystengcomm 15: 4565–4570.
18. Auffinger P, Hays FA, Westhof E, Ho PS (2004) Halogen bonds in biological
molecules. Proceedings of the National Academy of Sciences of the United States
of America 101: 16789–16794.
19. Voth AR, Ho PS (2007) The role of halogen bonding in inhibitor recognition
and binding by protein kinases. Current Topics in Medicinal Chemistry 7:
1336–1348.
20. Rendine S, Pieraccini S, Forni A, Sironi M (2011) Halogen bonding in ligand-
receptor systems in the framework of classical force fields. Physical Chemistry
Chemical Physics 13: 19508–19516.
21. Wang W, Okada Y, Shi HB, Wang YQ, Okuyama T (2005) Structures and
aldose reductase inhibitory effects of bromophenols from the red alga
Symphyocladia latiuscula. Journal of Natural Products 68: 620–622.
22. Hernandes MZ, Cavalcanti SMT, Moreira DRM, de Azevedo WF Jr, Lima
Leite AC (2010) Halogen Atoms in the Modern Medicinal Chemistry: Hints for
the Drug Design. Current Drug Targets 11: 303–314.
23. Pauletti PM, Cintra LS, Braguine CG, da Silva Filho AA, Andrade e Silva ML,
et al. (2010) Halogenated Indole Alkaloids from Marine Invertebrates. Marine
Drugs 8: 1526–1549.
24. Parisini E, Metrangolo P, Pilati T, Resnati G, Terraneo G (2011) Halogen
bonding in halocarbon-protein complexes: a structural survey. Chemical Society
Reviews 40: 2267–2278.
Halogen Atom Affects Hydrogen Bonding
PLOS ONE | www.plosone.org 8 June 2014 | Volume 9 | Issue 6 | e99984
25. Voth AR, Hays FA, Ho PS (2007) Directing macromolecular conformation
through halogen bonds. Proceedings of the National Academy of Sciences of the
United States of America 104: 6188–6193.
26. Voth AR, Khuu P, Oishi K, Ho PS (2009) Halogen bonds as orthogonal
molecular interactions to hydrogen bonds. Nature Chemistry 1: 74–79.
27. Wilcken R, Zimmermann MO, Lange A, Joerger AC, Boeckler FM (2013)
Principles and Applications of Halogen Bonding in Medicinal Chemistry and
Chemical Biology. Journal of Medicinal Chemistry 56: 1363–1388.
28. Poznanski J, Shugar D (2013) Halogen bonding at the ATP binding site of
protein kinases: Preferred geometry and topology of ligand binding. Biochimica
et Biophysica Acta 1834: 1381–1386.
29. Sarwar MG, Dragisic B, Salsberg LJ, Gouliaras C, Taylor MS (2010)
Thermodynamics of Halogen Bonding in Solution: Substituent, Structural,
and Solvent Effects. Journal of the American Chemical Society 132: 1646–1653.
30. Politzer P, Lane P, Concha MC, Ma Y, Murray JS (2007) An overview of
halogen bonding. Journal of Molecular Modeling 13: 305–311.
31. Hauchecorne D, van der Veken BJ, Moiana A, Herrebout WA (2010) The C-
ClNNNN halogen bond, the weaker relative of the C-I and C-BrNNNN halogen
bonds, finally characterized in solution. Chemical Physics 374: 30–36.
32. Metrangolo P, Murray JS, Pilati T, Politzer P, Resnati G, et al. (2011) Fluorine-
Centered Halogen Bonding: A Factor in Recognition Phenomena and
Reactivity. Crystal Growth & Design 11: 4238–4246.
33. Politzer P, Murray JS, Clark T (2010) Halogen bonding: an electrostatically-
driven highly directional noncovalent interaction. Physical Chemistry Chemical
Physics 12: 7748–7757.
34. An X, Zhuo H, Wang Y, Li Q (2013) Competition between hydrogen bonds and
halogen bonds in complexes of formamidine and hypohalous acids. Journal of
Molecular Modeling 19: 4529–4535.
35. Riley KE, Rezac J, Hobza P (2013) Competition between halogen, dihalogen
and hydrogen bonds in bromo- and iodomethanol dimers. Journal of Molecular
Modeling 19: 2879–2883.
36. Li Q, Xu X, Liu T, Jing B, Li W, et al. (2010) Competition between hydrogen
bond and halogen bond in complexes of formaldehyde with hypohalous acids.
Physical Chemistry Chemical Physics 12: 6837–6843.
37. Liu X, Cheng J, Li Q, Li W (2013) Competition of hydrogen, halogen, and
pnicogen bonds in the complexes of HArF with XH2P (X=F, Cl, and Br).
Spectrochimica Acta Part a-Molecular and Biomolecular Spectroscopy 101:
172–177.
38. Raatikainen K, Cametti M, Rissanen K (2010) The subtle balance of weak
supramolecular interactions: The hierarchy of halogen and hydrogen bonds in
haloanilinium and halopyridinium salts. Beilstein Journal of Organic Chemistry
6.
39. Aakeroey CB, Panikkattu S, Chopade PD, Desper J (2013) Competing
hydrogen-bond and halogen-bond donors in crystal engineering. Crystengcomm
15: 3125–3136.
40. Carter M, Ho PS (2011) Assaying the Energies of Biological Halogen Bonds.
Crystal Growth & Design 11: 5087–5095.
41. Hardegger LA, Kuhn B, Spinnler B, Anselm L, Ecabert R, et al. (2011)
Systematic Investigation of Halogen Bonding in Protein-Ligand Interactions.
Angewandte Chemie-International Edition 50: 314–318.
42. Xu Z, Liu Z, Chen T, Chen T, Wang Z, et al. (2011) Utilization of Halogen
Bond in Lead Optimization: A Case Study of Rational Design of Potent
Phosphodiesterase Type 5 (PDE5) Inhibitors. Journal of Medicinal Chemistry
54: 5607–5611.
43. Wasik R, Winska P, Poznanski J, Shugar D (2012) Isomeric Mono-, Di-, and
Tri-Bromobenzo-1H-Triazoles as Inhibitors of Human Protein Kinase CK2
alpha. Plos One 7: e48898.
44. Seela F, Peng XH, Li H (2005) Base-pairing, tautomerism, and mismatch
discrimination of 7-halogenated 7-deaza-29-deoxylsoguanosine: Oligonucleotide
duplexes with parallel and antiparallel chain orientation. Journal of the
American Chemical Society 127: 7739–7751.
45. Wasik R, Lebska M, Felczak K, Poznanski J, Shugar D (2010) Relative Role of
Halogen Bonds and Hydrophobic Interactions in Inhibition of Human Protein
Kinase CK2 alpha by Tetrabromobenzotriazole and Some C(5)-Substituted
Analogues. Journal of Physical Chemistry B 114: 10601–10611.
46. Wasik R, Winska P, Poznanski J, Shugar D (2012) Synthesis and Physico-
Chemical Properties in Aqueous Medium of All Possible Isomeric Bromo
Analogues of Benzo-1H-Triazole, Potential Inhibitors of Protein Kinases.
Journal of Physical Chemistry B 116: 7259–7268.
47. Kuopio R, Kivinen A, Murto J (1976) Hexamethylphosphoramide as Proton
Acceptor. Part 1. A Near-infrared Study of Its Heteroassociation with Ordinary
and Halogenated Alcohols. Acta Chemica Scandinavica A 30: 1–7.
48. Guerra CF, Wijst T, Bickelhaupt FM (2005) Substituent effects on hydrogen
bonding in Watson-Crick base pairs. A theoretical study. Structural Chemistry
16: 211–221.
49. Heshmati E, Abdolmaleki P, Mozdarani H, Sarvestani AS (2009) Effects of
halogen substitution on Watson-Crick base pairing: A possible mechanism for
radiosensitivity. Bioorganic & Medicinal Chemistry Letters 19: 5256–5260.
50. Lozinski T, Wierzchowski KL (2001) Mg2+ ions do not induce expansion of the
melted DNA region in the open complex formed by Escherichia coli RNA
polymerase at a cognate synthetic Pa promoter. A quantitative KMnO4
footprinting study. Acta Biochimica Polonica 48: 495–510.
51. Simpson RT, Seale RL (1974) Characterization of chromatin extensively
substituted with 5-bromodeoxyuridine. Biochemistry 13: 4609–4616.
52. Cullen BR, Bick MD (1976) Thermal denaturation of DNA from bromodeoxy-
uridine substituted cells. Nucleic Acids Res 3: 49–62.
53. Inman R, Baldwin R (1962) Formation of hybrid molecules from two alternating
DNA copolymers. J Mol Biol 5: 185–200.
54. Inman R, Baldwin R (1962) Helix-random coil transitions in synthetic DNAs of
alternating sequence. J Mol Biol 5: 172–184.
55. Inman RB, Baldwin RL (1964) Helix-random coil transitions in DNA
homopolymer pairs. J Mol Biol 8: 452–469.
56. Kuhn B, Mohr P, Stahl M (2010) Intramolecular Hydrogen Bonding in
Medicinal Chemistry. Journal of Medicinal Chemistry 53: 2601–2611.
57. Vulpetti A, Dalvit C (2012) Fluorine local environment: from screening to drug
design. Drug Discovery Today 17: 890–897.
58. Scholfield MR, Vander Zanden CM, Carter M, Ho PS (2013) Halogen bonding
(X-bonding): A biological perspective. Protein Science 22: 139–152.
59. Lu Y, Liu Y, Xu Z, Li H, Liu H, et al. (2012) Halogen bonding for rational drug
design and new drug discovery. Expert Opinion on Drug Discovery 7: 375–383.
60. Zhou P, Tian F, Zou J, Shang Z (2010) Rediscovery of Halogen Bonds in
Protein-Ligand Complexes. Mini-Reviews in Medicinal Chemistry 10: 309–314.
61. Baldrighi M, Cavallo G, Chierotti MR, Gobetto R, Metrangolo P, et al. (2013)
Halogen Bonding and Pharmaceutical Cocrystals: The Case of a Widely Used
Preservative. Molecular Pharmaceutics 10: 1760–1772.
62. Jeffrey GA, Saenger W (1994) Hydrogen Bonding in Biological Structures:
Springer.
63. Protein Data Bank; Available: http://www.rcsb.org; Downloaded October
2012.
64. Krieger E, Joo K, Lee J, Lee J, Raman S, et al. (2009) Improving physical
realism, stereochemistry, and side-chain accuracy in homology modeling: Four
approaches that performed well in CASP8. Proteins-Structure Function and
Bioinformatics 77: 114–122.
65. Anderson TW, Darling DA (1952) Asymptotic theory of certain goodness of fit
criteria based on stochastic processes. Annals of Mathematical Statistics 23: 193–
212.
66. Mann HB, Whitney DR (1947) On a test of whether one of two random
variables is stochastically larger than the other. Annals of Mathematical Statistics
18: 50–60.
67. Kruskal WH, Wallis WA (1952) Use of ranks in one-criterion variance analysis.
Journal of the American Statistical Association 47: 583–621.
68. Freidlin B, Gastwirth JL (2000) Should the median test be retired from general
use? American Statistician 54: 161–164.
69. (2011) STATISTICA (data analysis software system) version 10. StatSoft, Inc.
Halogen Atom Affects Hydrogen Bonding
PLOS ONE | www.plosone.org 9 June 2014 | Volume 9 | Issue 6 | e99984
